EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinie

2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship

Marcelo Borges Cavalcante iD, Conor Harrity iD, Thanh Luu iD, Joy Fatunbi iD, Koji Nakagawa iD, Yuan Zhang iD, Tao Zhang iD, Hallah Alanazi iD, Li Wu iD, Sungki Lee iD, Ricardo Barini iD, Joanne Kwak-Kim iD

American Journal of Reproductive Immunology · 2025-06 · 93 (6)

DOI: 10.1111/aji.70099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 30.05.2025. Verfasst von Marcelo Borges Cavalcante und 11 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR), Fortaleza, Brazil. Hauptthemen laut MEDLINE: Abortion, Habitual, Immunotherapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 208 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various immunomodulatory treatments have been applied to women with recurrent pregnancy losses since a significant proportion of them have cellular and autoimmune abnormalities. However, immunomodulatory treatments are often considered controversial for their efficacies. Often, they are provided to unselected patients without investigating potential etiologies by healthcare providers without appropriate reproductive immunology training and qualifications. To eliminate these concerns, the American Society for Reproductive Immunology (ASRI) established the Clinical Reproductive Immunology Fellowship and has been certifying reproductive immunologists. The approach to RPL from a reproductive immunology perspective requires a detailed understanding of underlying immunopathology, advanced knowledge of clinical and basic science and translational research, and the capability to evaluate the available evidence. The immunotherapy guideline development group, composed of clinical reproductive immunology fellows, ASRI, reviewed the currently available data and developed the clinical guidelines for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualImmunotherapyHumansFemalePregnancyAllergy and ImmunologyFellowships and ScholarshipsUnited StatesReproductive MedicineSocieties, Medical

Stichwörter der Autor:innen

guidelinesimmunotherapyrecurrent miscarriagerecurrent pregnancy lossrecurrent spontaneous abortion

Autor:innen und Institutionen

  • Postgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR), Fortaleza, Brazil.
  • RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Reproductive Medicine and Immunology, Obstetrics and Gynecology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, USA.
  • Center for Reproductive Medicine and Implantation Research Sugiyama Clinic Shinjuku Tokyo, Tokyo, Japan.
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Center of Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
  • Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.

ORCID-Profile: Marcelo Borges Cavalcante, Conor Harrity, Thanh Luu, Joy Fatunbi, Koji Nakagawa, Yuan Zhang, Tao Zhang, Hallah Alanazi, Li Wu, Sungki Lee, Ricardo Barini, Joanne Kwak-Kim

Zitieren

APA

Cavalcante, M. B., Harrity, C., Luu, T., Fatunbi, J., Nakagawa, K., Zhang, Y., Zhang, T., Alanazi, H., Wu, L., Lee, S., Barini, R., & Kwak-Kim, J. (2025). 2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship. American Journal of Reproductive Immunology, 93(6). https://doi.org/10.1111/aji.70099

Vancouver

Cavalcante MB, Harrity C, Luu T, Fatunbi J, Nakagawa K, Zhang Y, et al. 2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship. American Journal of Reproductive Immunology. 2025;93(6). doi:10.1111/aji.70099

BibTeX
@article{Cavalcante2025,
  author = {Cavalcante, Marcelo Borges and Harrity, Conor and Luu, Thanh and Fatunbi, Joy and Nakagawa, Koji and Zhang, Yuan and Zhang, Tao and Alanazi, Hallah and Wu, Li and Lee, Sungki and Barini, Ricardo and Kwak-Kim, Joanne},
  title = {2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  volume = {93},
  number = {6},
  doi = {10.1111/aji.70099}
}
Kostenlos starten →